Insights into CYP17A1 activities and binding of anti-prostate cancer drug abiraterone
IMechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency
Fluck CE & Pandey, AV. Clinical and biochemical consequences of P450
oxidoreductase deficiency. Endocr. Dev 20:63-79 (2011)
On cover P450, b5
Fluck CE, Pandey AV, Huang N, Agrawal V, Miller WL. P450
oxidoreductase deficiency - a new form of congenital adrenal hyperplacia. Endocr Dev, 13: 67-81 (2008).
On the cover: POR
Pandey, AV and Miller, WL. Regulation of 17,20 lyase activity by cytochrome
b5 and by serine phosphorylation of P450c17. J. Biol Chem. 280: 13265-13271 (2005)
April 08, 2005 Cover Page.
Pandey, AV and Chauhan, VS Heme polymerisation by malarial parasite
: A potential target for antimalarial drug development. Current Sc. 75:911-918 (1998).
Role of Human P450 Oxidoreductase in steroid metabolism